Cutler Group LP Regenxbio Inc. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	BUY	$12.17 - $24.61 $1,217 - $2,461	100 New	100 $0
Q2 2023 Jul 18, 2023	SELL	$17.23 - $21.71 $51,690 - $65,130	-3,000 Reduced 71.43%	1,200 $12,000
Q1 2023 May 01, 2023	BUY	$18.08 - $24.55 $21,695 - $29,460	1,200 Added 40.0%	4,200 $31,000
Q4 2022 Feb 07, 2023	SELL	$20.4 - $24.73 $40,800 - $49,460	-2,000 Reduced 40.0%	3,000 $13,000
Q2 2022 Aug 04, 2022	BUY	$19.35 - $35.04 $96,750 - $175,200	5,000 New	5,000 $20,000
Q4 2021 Jan 18, 2022	SELL	$30.19 - $40.28 $196,235 - $261,820	-6,500 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$29.09 - $45.68 $95,997 - $150,744	3,300 Added 103.13%	6,500 $7,000
Q1 2020 May 07, 2020	BUY	$21.5 - $54.2 $62,350 - $157,180	2,900 Added 966.67%	3,200 $26,000
Q4 2019 Feb 06, 2020	SELL	$34.54 - $44.87 $51,810 - $67,305	-1,500 Reduced 83.33%	300 $0
Q3 2019 Oct 28, 2019	SELL	$31.84 - $50.88 $229,248 - $366,336	-7,200 Reduced 80.0%	1,800 $16,000
Q2 2019 Aug 09, 2019	SELL	$42.0 - $59.29 $205,800 - $290,521	-4,900 Reduced 35.25%	9,000 $114,000
Q1 2019 May 10, 2019	BUY	$40.82 - $62.45 $355,134 - $543,315	8,700 Added 167.31%	13,900 $126,000
Q4 2018 Feb 05, 2019	BUY	$39.11 - $75.15 $27,377 - $52,605	700 Added 15.56%	5,200 $68,000
Q3 2018 Nov 07, 2018	SELL	$65.0 - $82.15 $175,500 - $221,805	-2,700 Reduced 37.5%	4,500 $20,000
Q2 2018 Aug 10, 2018	BUY	$27.2 - $74.35 $136,000 - $371,750	5,000 Added 227.27%	7,200 $0
Q1 2018 May 11, 2018	BUY	$24.05 - $37.5 $26,455 - $41,250	1,100 Added 100.0%	2,200 $5,000
Q4 2017 Jan 17, 2018	SELL	$26.0 - $34.6 $70,200 - $93,420	-2,700 Reduced 71.05%	1,100 $0
Q3 2017 Oct 17, 2017	BUY	$18.0 - $32.95 $68,400 - $125,210	3,800	3,800 $0

Others Institutions Holding RGNX

# of Institutions

197

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $439M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account